For research use only. Not for therapeutic Use.
Meclofenamate sodium (Cat No.:A000129) is a dual COX-1/COX-2 inhibitor with IC50s of 40 nM and 50 nM, respectively, for the treatment of joint and muscle pain, arthritis, and dysmenorrhea.Meclofenamate sodium is also a non-selective gap junction blocker and a highly selective inhibitor of adiposity and obesity-related ( FTO) enzyme inhibitor.
Catalog Number | A000129 |
CAS Number | 6385-02-0 |
Synonyms | MECLOFENAMATE SODIUM; Meclomen; Sodium meclofenamate; Meclonax; Movens; Meclofenamic acid sodium |
Molecular Formula | C14H10Cl2NNaO2 |
Purity | ≥95% |
Target | Metabolic Enzyme/Protease |
Solubility | Soluble in DMSO > 10 mM |
Storage | Store at -20°C |
InChI | 1S/C14H11Cl2NO2.Na/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19;/h2-7,17H,1H3,(H,18,19);/q;+1/p-1 |
InChIKey | OGPIIGMUPMPMNT-UHFFFAOYSA-M |
SMILES | CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+] |
Reference | 1: Ghosh R, Hwang SM, Cui Z, Gilda JE, Gomes AV. Different effects of the 2: Hersh EV, Cooper S, Betts N, Wedell D, MacAfee K, Quinn P, Lamp C, Gaston G, 3: Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy 4: Mongini F, Bona G, Garnero M, Gioria A. Efficacy of meclofenamate sodium 5: Benassi L, Bertani D, Avanzini A. An attempt at real prophylaxis of primary 6: Conroy MC, Randinitis EJ, Turner JL. Pharmacology, pharmacokinetics, and 7: Giglio JA, Laskin DM. Double-blind comparison of meclofenamate sodium plus <br> 9: Shieh HL, Hutton CE, Kafrawy AH, Potter RH. Comparison of meclofenamate sodium <br> |